{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Shanghai RAAS Blood Products Co., Ltd.
Shanghai RAAS Blood Products Hits Day High with 3.23% Surge
Shanghai RAAS Blood Products Co., Ltd. saw a significant intraday gain, contrasting with the modest rise of the China Shanghai Composite. Despite this, the company has struggled over the past year, facing a notable decline in net profit and negative operating cash flow, indicating ongoing financial challenges.
Shanghai RAAS Blood Products Hits Day Low Amid Price Pressure at CNY 5.73
Shanghai RAAS Blood Products Co., Ltd. has faced significant stock declines, with a notable drop today and a one-year decrease of 16.79%. The company's market capitalization is CNY 42,046 million, and it operates in the Pharmaceuticals & Biotechnology sector, highlighting ongoing financial challenges.
Shanghai RAAS Blood Products Hits Day Low of CNY 6.00 Amid Price Pressure
Shanghai RAAS Blood Products Co., Ltd. saw a significant stock decline today, contrasting with the broader market's performance. The company has faced ongoing challenges, including a notable drop in net profit and a low return on equity, reflecting difficulties in growth over the past year and beyond.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
